Capacity Bio, Inc.
Capacity Bio is a private, Los Angeles-based biotech company developing a first-in-class mitophagy therapeutic platform. Their mission is to target mitochondrial biology to power therapeutic breakthroughs by developing small molecules, peptides, and nanoparticles that enhance mitochondrial quality and function. They focus on neurodegenerative and autoimmune disorders, myopathies, and genetic orphan indications, aiming to advance mitochondrial health and treat various diseases.
Industries
Nr. of Employees
small (1-50)
Capacity Bio, Inc.
570 Westwood Plaza, Bldg 114, Los Angeles CA 90095
Patents
Methods and agents that stimulate mitochondrial turnover for treating disease
US-12343331-B2
View Details
Methods and agents that stimulate mitochondrial turnover for treating disease
US-12343331-B2
View DetailsProducts
Mitophagy therapeutic platform
A platform for discovering and developing agents that induce mitochondrial turnover and improve mitochondrial quality, used to generate pipeline candidates across multiple disease areas.
Mitochondrial characterization analytical toolkit
Analytical tools and platforms developed to characterize mitochondrial quality, function, and turnover to support discovery and preclinical assessment.
Mitophagy therapeutic platform
A platform for discovering and developing agents that induce mitochondrial turnover and improve mitochondrial quality, used to generate pipeline candidates across multiple disease areas.
Mitochondrial characterization analytical toolkit
Analytical tools and platforms developed to characterize mitochondrial quality, function, and turnover to support discovery and preclinical assessment.
Services
End-to-end discovery and preclinical advancement of therapeutic candidates that modulate mitophagy, including target identification, candidate generation, and preclinical evaluation.
End-to-end discovery and preclinical advancement of therapeutic candidates that modulate mitophagy, including target identification, candidate generation, and preclinical evaluation.
Expertise Areas
- Mitophagy-focused therapeutic development
- Mitochondrial biology and target discovery
- Preclinical drug discovery and candidate selection
- Mitochondrial analytical platform development
Key Technologies
- Small-molecule therapeutics
- Peptide therapeutics
- Nanoparticle delivery systems
- Mitochondrial functional and quality assays